30% Supramolecular Salicylic Acid Improved Symptoms and Skin Barrier in Papulopustular Rosacea
30% SSA reduced papules and pustules in rosacea, improved persistent erythema, and enhanced stratum corneum hydration in the 30% SSA-treated group compared to the placebo group. No significant differences were observed in TEWL and skin pH values between the two groups. Our findings suggest that 30% SSA is an effective and safe option for managing papulopustular rosacea, offering a well-tolerated alternative to traditional treatments.
Authors
- Xian Su (ORCID: https://orcid.org/0000-0002-8295-876X)
- Zihan Wang (ORCID: https://orcid.org/0000-0002-4284-0513)
- Yutong Wu (ORCID: https://orcid.org/0000-0001-5897-6813)
- Xing‐Hua Gao (ORCID: https://orcid.org/0000-0001-8809-8564)
- Zhiyun Yang (ORCID: https://orcid.org/0000-0002-3202-9022)
- Fatemeh Nozzari Varkani
Institutions
- Soochow University (CN)
- ShenZhen People’s Hospital (CN)
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Cosmetic Dermatology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/jocd.70046
- Citations
- 2
- Primary Topic
- Acne and Rosacea Treatments and Effects
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China